Amsurg (AMSG) Tops Q3 EPS by 9c, Updates FY Guidance

Go back to Amsurg (AMSG) Tops Q3 EPS by 9c, Updates FY Guidance

AmSurg Reports Third-Quarter Adjusted Diluted EPS of $1.03 and Diluted EPS of $0.83

November 3, 2015 4:05 PM EST

Increases 2015 Financial Guidance

NASHVILLE, Tenn.--(BUSINESS WIRE)-- AmSurg Corp. (NASDAQ: AMSG) today announced financial results for the third quarter ended September 30, 2015. The Companys results for the quarter included:

Growth in net revenues of 29% to $650.2 million from $502.4 million for the third quarter of 2014; Net earnings from continuing operations attributable to AmSurg common shareholders of $40.4 million. Adjusted net earnings increased 53% to $53.0 million from the third quarter of 2014; Net earnings per diluted share from continuing operations attributable to AmSurg common... More